Article Details

Astellas Pharma : Notice Regarding Impairment Loss Following the Termination of DNA Vaccine ...

Retrieved on: 2021-06-17 06:56:15

Tags for this article:

Click the tags to see associated articles and topics

Astellas Pharma : Notice Regarding Impairment Loss Following the Termination of DNA Vaccine .... View article details on HISWAI: https://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-nbsp-Notice-Regarding-Impairment-Loss-Following-the-Termination-of-DNA-Vaccine-ASP-35629557/

Excerpt

ASP0892 is the DNA vaccine using the LAMP-Vax platform, that was in-licensed from Immunomic Therapeutics, Inc. About Astellas. Astellas Pharma ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up